[Interleukin 18 expression in colon cancer and adenoma].

Sichuan Da Xue Xue Bao Yi Xue Ban

Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu 610041, China.

Published: April 2003

Objective: To investigate the expression of interleukin 18 in mucosa of colon cancer and adenoma.

Methods: Expression of interleukin 18 was measured with immunohistochemical staining.

Results: The expression rates of IL-18 in colon cancer, adenoma and relative normal mucosa were 78.8%, 100% and 100%, respectively (P > 0.05). In the case of colon cancer, the higher the cancer was differentiated, the higher the IL-18 expression level was observed (P < 0.05). In the case of colon adenoma, no significant relation was noted between the grade of dysplasia and the expression of IL-18 (P > 0.05).

Conclusion: In colon adenoma, all mucosae express IL-18. But in colon cancer, IL-18 expression is decreased or absent, and the lower the cancer is differentiated, the lower will be the level of IL-18 expression in epithelium.

Download full-text PDF

Source

Publication Analysis

Top Keywords

colon cancer
20
il-18 expression
12
expression interleukin
8
il-18 colon
8
005 case
8
case colon
8
cancer differentiated
8
colon adenoma
8
colon
7
cancer
7

Similar Publications

CCL3 as a novel biomarker in the diagnosis of necrotizing enterocolitis.

BMC Pediatr

December 2024

Department of Clinical Laboratory, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Infection and Immunity, Children's Hospital of Chongqing Medical University, NO 136 Zhongshaner Road, Yuzhong Distrit, Chongqing, 400014, China.

Objectives: Neonatal necrotizing enterocolitis (NEC) is a common intestinal disease that threatens the lives of newborns and is characterized by ischemic necrosis of the small intestine and colon. As early diagnosis of NEC improves prognosis, the identification of new or complementary biomarkers is of great importance. In this study, we evaluate the diagnostic value of CCL3 in NEC and compare its effectiveness with other commonly used biomarkers, such as procalcitonin (PCT) and C-reactive protein (CRP).

View Article and Find Full Text PDF

Should endoscopic submucosal dissection be offered to patients with early colorectal cancer?

Surgery

December 2024

Department of Colorectal Surgery, Digestive Disease & Surgery Institute, Cleveland Clinic, Cleveland, OH. Electronic address:

Background: Endoscopic submucosal dissection is increasingly used to treat early-stage colorectal cancer. This study evaluated the feasibility of endoscopic submucosal dissection in this setting and the determinants of lymph node metastasis.

Methods: We reviewed patients who underwent colorectal endoscopic submucosal dissection for early-stage colorectal cancer at a tertiary center between 2011 and 2023.

View Article and Find Full Text PDF

Comprehensive analysis of heterogeneity and cell-cell interactions in Crohn's disease reveals novel location-specific insights.

J Adv Res

December 2024

Department of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Shanghai Institute of Digestive Disease, Inflammatory Bowel Disease Research Center, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Division of Gastroenterology and Hepatology, Baoshan Branch, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Electronic address:

Introduction: In Crohn's disease (CD), lesions are mainly distributed in a segmental manner, with the primary sites of involvement being the ileum and colon. Heterogeneity in colon and ileum results in location-specific clinical presentations and therapeutic responses. Mucosal healing tends to be more readily and quickly achieved in the colon than in the ileum, where lesions are more likely to develop into complex behaviors.

View Article and Find Full Text PDF

Sesamolin possesses limited aqueous solubility, a drawback for biological activity study in cancer cell models. This study aimed to enhance sesamolin's ability to fight cancer, as it is a bioactive compound with low water solubility found in sesame. We developed different Pickering emulsion delivery systems and tested their anticancer effects on various cancer cell types.

View Article and Find Full Text PDF

Development and validation of machine learning models for predicting venous thromboembolism in colorectal cancer patients: A cohort study in China.

Int J Med Inform

December 2024

Chongqing Cancer Multiomics Big Data Application Engineering Research Center, Chongqing University Cancer Hospital, Chongqing 400030, China. Electronic address:

Background: With advancements in healthcare, traditional VTE risk assessment tools are increasingly insufficient to meet the demands of high-quality care, underscoring the need for innovative and specialized assessment methods.

Objective: Owing to the remarkable success of machine learning in supervised learning and disease prediction, our objective is to develop a reliable and efficient model for assessing VTE risk by leveraging the fundamental data and clinical characteristics of colorectal cancer patients within our medical facility.

Methods: Six commonly used machine learning algorithms were utilized in our study to predict the occurrence of VTE in patients with rectal cancer.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!